Clinical Trials in Montreal, QC
Here are the 6 most popular medical studies in montreal
Neuromodulation Device
FibroNova Neuromodulation Device for Fibromyalgia
Recruiting0 awards
Springfield, Missouri
This trial examines a new technology called Remote Electrical Neuromodulation (REN) for treating fibromyalgia pain. REN uses non-painful signals to activate the body's pain management system
Popular filter options for montreal trials
Phase 3 Clinical Trials
View 96 phase 3 medical studies.
Cancer Vaccine
COVID-19 Vaccine +3 More for COVID-19
Recruiting1 awardPhase 3
Athens, Alabama
This trial is studying the safety and effects of a combined influenza and COVID-19 vaccine. The goal is to see if giving both vaccines at the same time can provide better protection against both diseases. Around
Clinical Trials With No Placebo
View 96 medical studies that do not have a placebo group.
Behavioural Intervention
Heated Tobacco Products for Tobacco Use
Recruiting1 award
Lexington, Kentucky
This trial will test the nicotine levels and effects of different Heated Tobacco Products on adult smokers. Participants will try two menthol and two tobacco flavored HTPs, along with their usual brand of cigarettes
Behavioural Intervention
Cost Communication and Financial Navigation (CostCOM) for Cancer
Recruiting1 award
Fort Smith, Arkansas
This trial looks at how a program called Cost Communication and Financial Navigation (CostCOM) can help cancer patients with their medical costs and financial stress. Cancer patients often struggle with high medical costs and financial difficulties
Behavioural Intervention
SHINE Program for Breast Cancer
Recruiting1 award
Winston-Salem, North Carolina
"This trial aims to create an online program to help breast cancer survivors deal with sexual concerns related to cancer. Participants will be split into different groups and given access to the SHINE program, which provides education
GLP-1 Agonist Group for Diabetes
Recruiting3 awardsPhase 4
Columbia, Missouri
Glucagon-like peptide 1 (GLP-1) is a hormone that helps regulate blood glucose levels through improved insulin sensitivity and release of insulin from the pancreas, control hunger, induce satiety and plays a role in the metabolic health of a person. GLP-1 receptor agonists (GLP1-RAs) have been shown to be effective in achieving weight loss in patients with type 2 diabetes while improving blood glucose control. Bariatric surgical procedures have been shown to be effective in treating obesity as well as superior to best medical therapy for treatment of diabetes not just through restriction of calories but also through a positive impact in modifications of gut hormones, changes in circulating bile acids, modifications in the gut microflora as well as other undefined mechanisms. The combined benefits of GLP1-RAs with bariatric surgery have only been studied to a limited effect. In this randomized trial, the effects of continuation or discontinuation of GLP1-RA therapy in patients undergoing bariatric surgery will be determined. We will compare changes in weight, metabolic determinants including circulating bile acids and gut microbiome, psychological determinants of eating behavior, and adverse side effects in patients who continue vs discontinue therapy. Given differences in metabolic and clinical outcomes in patients undergoing vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass (RYGB), both surgical groups will be examined. The study will be conducted at a high volume bariatric surgical program where patients will undergo randomization at the time of final clinic visit prior to surgery to continue or discontinue GLP1-RA. It is hypothesized that participants who continue GLP1-RA therapy after bariatric surgery will lose more weight with improved blood glucose control than those who discontinue therapy. Furthermore, changes in gut microbiome and circulating bile acids, known determinants of metabolic health, will be modified to a differential extent in those who are on GLP1-RAs vs those where GLP1-RAs are discontinued. Understanding the role these medications play in not only clinical outcomes after metabolic surgery but potential metabolic mechanisms by which surgery improves patient's metabolic health could help people with obesity and type 2 diabetes make informed decisions about their treatment options as well as advise providers on the continuation of these medications in the perioperative and postoperative period.
View More Montreal Trials
See another 76 medical studies focused on montreal.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.